Skip to main content
. 2025 Jul 15;14(14):4990. doi: 10.3390/jcm14144990
Anti-TNF-α Tumor necrosis factor-alpha inhibitors
aOR Adjusted odds ratio
BCG Bacillus Calmette-Guérin
CI Confidence interval
DMARDs Disease-modifying antirheumatic drugs
HBV Hepatitis B virus
HCV Hepatitis C virus
HIV Human immunodeficiency virus
IGRAs Interferon-gamma release assays
IMIDs Immune-mediated inflammatory diseases
JAKi Janus kinase inhibitors
LTBI Latent tuberculosis infection
OR Odds ratio
QFT-Plus QuantiFERON-TB Gold Plus
TB Tuberculosis
TNF-α Tumor necrosis factor-alpha
TST Tuberculin skin test